Top Takeaways | Specialty Spotlight: Gastroenterology

McDermott Will & Emery
Contact

McDermott Will & Emery

In this moderated session featuring perspectives from top gastroenterology (GI) executives, panelists explored the thriving state of marketing and dealmaking in this field.

Session panelists included:

  • Robbie Allen, Chief Executive Officer, One GI
  • Matt Devine, Chief Executive Officer, Allied Digestive Health
  • Michael Kroin, Chief Executive Officer and managing partner, Physician Growth Partners
  • Samuel Vaill, Chief Development Officer, United Digestive
  • Moderator: Amanda Jester, Partner, McDermott Will & Emery

IN DEPTH


Top takeaways included:

  1. Gastroenterology continues to be an attractive specialty for investment. This is due to a number of factors, including gastroenterology’s diverse revenue streams that can provide income repair for physicians and generate alignment among stakeholders. The increased push for outpatient surgical care to lower costs of care and the decreasing age of patients seeking colonoscopies and other gastroenterology procedures provide investors with significant runways to drive growth.
  2. As labor costs increase and challenges in the healthcare industry continue, physician practice management organizations provide gastroenterology groups with economies of scale, the ability to develop ancillaries and strong recruiting programs, as well as leverage against disruption by payors, hospital systems and competitors. Other advantages include access to expansive clinical data for research and development and improved point-of-care support.
  3. Culture is an oft-overlooked factor in gastroenterology transactions. Because transactions are intended to foster long-term arrangements, ensuring cultural alignment is key for the future success of a platform. Physicians should also consider the ways in which the platform focuses on the physician and the support of their practice as well as the role of physician leadership and governance.
  4. Hospitals can serve as critical partners for gastroenterology platforms on outpatient services. Platforms should expect more interest from hospitals as they look to participate in the continuum of care outside the hospital.

[View source.]

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McDermott Will & Emery | Attorney Advertising

Written by:

McDermott Will & Emery
Contact
more
less

McDermott Will & Emery on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide